The activities of the new compounds and cisplatin were investigated in human tumour cell lines: (a) MDA-MB-468 (human epithelial breast adenocarcinoma);24 (b) HCT116 p53+/+ and (c) HCT116 p53–/–. Here, TP53 is linked to neoplasm.